Chemsex linked with increased diagnoses of HIV and other sexually transmitted infections

May 23, 2018, Wiley

Chemsex—the use of crystallised methamphetamine, mephedrone, γ-hydroxybutyrate or γ-butyrolactone and to a lesser extent cocaine and ketamine to facilitate sex—has emerged as a new phenomenon in the UK and across Europe amongst gay, bisexual and other men who have sex with men (GBMSM). A new HIV Medicine study reveals that chemsex disclosure in sexual health settings is associated with higher rates of new diagnoses of HIV, Hepatitis C, and other sexually transmitted infections.

For the study, researchers reviewed information on all GBMSM attending 2 London sexual health clinics over a 13 month period. Those who reported that they had participated in chemsex were 5-times more likely to have a new diagnosis of HIV than those who had not participated in chemsex.

Although it was not possible to determine if chemsex causes HIV infection, the investigators note that use of drugs in sexual settings and alcohol has been linked with condomless anal sex and other behaviours predisposing to HIV transmission.

"These are the first published data clearly demonstrating a link between a new HIV diagnosis and Chemsex," said senior author Dr. Aseel Hegazi, of St. George's University Hospital Foundation Trust, in London. "At risk GBMSM participating in Chemsex should access prevention strategies such as , or PrEP, and there is a need to increase public awareness regarding the potential consequences of Chemsex."

Explore further: 'Chemsex' needs to become a public health priority

More information: HIV Medicine, DOI: 10.1111/hiv.12629

Related Stories

'Chemsex' needs to become a public health priority

November 3, 2015
Chemsex - sex under the influence of illegal drugs - needs to become a public health priority, argue experts in The BMJ this week.

More gay men than ever getting tested for HIV—but 1 in 4 still never had a test

June 20, 2016
More gay and bisexual men than ever are getting tested for HIV, according to new data from the National Gay Men's Sex Survey. The survey is the largest of its kind in the UK and sheds light on the sexual health of men who ...

Campaigner with drug past warns of 'chemsex' HIV link

July 20, 2017
The sexual health expert credited with coining the term "chemsex" told AFP that drug-laced sexual encounters are boosting HIV infections in gay communities.

Research suggests stigma could inhibit access to HIV prevention drug

December 8, 2016
The first study to explore United Kingdom men's perceptions of PrEP – a new HIV prevention treatment – has found that their opinions are negatively influenced by social stigma. The article published in Cogent Medicine ...

Protecting young adults' sexual health

April 10, 2018
Gilla Shapiro studies clinical psychology at McGill. She earned her BA and MA in Social and Political Sciences at the University of Cambridge and dual degrees in public policy and public administration at the Hertie School ...

PrEP and targeted intervention strategies effective in high risk adolescent sexual minority males

January 8, 2018
Pre-exposure prophylaxis (PrEP) along with targeted implementation strategies have the potential to significantly reduce HIV incidence among high risk, adolescent sexual minority males (ASMM), according to a recent study ...

Recommended for you

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

September 21, 2018
Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously ...

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

New study finds HIV outbreak in Indiana could have been prevented

September 13, 2018
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health ...

Largest study of 'post-treatment controllers' reveals clues about HIV remission

September 13, 2018
Most HIV patients need to take daily anti-retroviral therapy—if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small fraction of patients can stop taking medications ...

Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

September 12, 2018
Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study.

Special antibodies could lead to HIV vaccine

September 10, 2018
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.